Alvos Therapeutics is a biopharmaceutical provider to use in vivo phage display technology systematically to develop novel cancer drugs. Alvos was founded to translate the research into effective cancer therapeutics. The company is formerly known as Mercator Therapeutics, Inc.In April 2012, Alvos Therapeutics was acquired by Arrowhead Research. The valuation of Alvos Therapeutics was undisclosed. Other terms of the deal were not released.
Alvos Therapeutics Headquarter Location
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Expert Collections containing Alvos Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Alvos Therapeutics is included in 3 Expert Collections, including Pharma Startups.
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.